Reuters' Paratek-To-Merck-Vs.-Hospira Patent Reporting: Confused -- But I'm Out Of Time, Today.

The usually reliable Reuters service put out an overnight story -- on Hospira's attempts (now owned by Pfizer) to launch a generic version of Invanz^® (purporting to cover the patent spats involved) -- that is (at best) confusing.

Here is the full memorandum opinion (a 49 page PDF file) from last Friday in Delaware federal District Court.

You should read it for yourself -- but the upshot is that it will be immaterial to Kenilworth.

If and when I find some quiet time, I'll be back to explain what's really going on here. Until then -- best to all. As ever, life intervenes -- smile. . .

नमस्ते